BIODELIVERY SCIENCES INTERNATIONAL overview

BIODELIVERY SCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioDelivery Sciences International, Inc. - BDSI PR Newswire NEW ORLEANS, Feb. 16, 2022 NEW ORLEANS , Feb. 16, 2022 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of BioDelivery Sciences International, Inc....

SHAREHOLDER ALERT: WeissLaw LLP Investigates BioDelivery Sciences International, Inc. PR Newswire NEW YORK, Feb. 15, 2022 NEW YORK , Feb. 15, 2022 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of BioDelivery Sciences International, Inc. ("BioDelivery" or the "Company") (NASDAQ: BDSI), in connection with the proposed acquisition of the Company by Collegium Pharmaceutical, Inc. ("Collegium") (NASDAQ: COLL)...

Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of BioDelivery Sciences International, Inc. (NASDAQ: BDSI) to Collegium Pharmaceutical, Inc. for $5.60 per share is fair to BioDelivery shareholders. Halper Sadeh encourages BioDelivery shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected] . The investigation concerns whether...

Shareholder Alert: Ademi LLP investigates whether BioDelivery Sciences International, Inc. has obtained a Fair Price in its transaction with Collegium. PR Newswire MILWAUKEE, Feb. 14, 2022 MILWAUKEE , Feb. 14, 2022 /PRNewswire/ -- Ademi LLP is investigating BioDelivery Sciences (NASDAQ: BDSI) for possible breaches of fiduciary duty and other violations of law in its transaction with Collegium. Click here to learn how to join the action:...

Thinking about buying stock in BioDelivery Sciences, China Online Education, Gold Fields, Y-mAbs Therapeutics, or Bloom Energy? PR Newswire NEW YORK, Feb. 14, 2022 NEW YORK , Feb. 14, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BDSI, COE, GFI, YMAB, and BE. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. BDSI:...

Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, hereafter known as “Dr. Reddy’s”), announced today that it has entered into a definitive asset purchase agreement, pursuant to which Dr. Reddy’s will sell its U.S. and Canada territory rights for ELYXYB (celecoxib oral solution) 25 mg/mL, to BioDelivery Sciences International, Inc. (BDSI). Under the terms of agreement, Dr.Reddy’s will receive U.S.$6 million upfront upon closing followed by...

...

Emmy® and Tony Award® Winning Actress Kristin Chenoweth Introduces 'This Is Pain' Campaign to Improve the Lives of Those Living with Chronic Pain Chenoweth Partners with BioDelivery Sciences to End Stigma Around Chronic Pain and Inspire Positive Change for Patients PR Newswire RALEIGH, N.C., Dec. 11, 2019 RALEIGH, N.C. , Dec. 11, 2019 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to...